Suppr超能文献

SWI/SNF 复合物调节 miR-222 的表达,miR-222 是肺腺癌中的一种肿瘤抑制 microRNA。

The SWI/SNF complex regulates the expression of miR-222, a tumor suppressor microRNA in lung adenocarcinoma.

机构信息

Department of Biochemistry and Molecular Biology I, University of Granada, Granada 18071, Spain.

GENYO, Centre for Genomics and Oncological Research, Pfizer/University of Granada/Andalusian Regional Government, Granada 18016, Spain.

出版信息

Hum Mol Genet. 2021 Nov 16;30(23):2263-2271. doi: 10.1093/hmg/ddab187.

Abstract

SWitch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complexes are key epigenetic regulators that are recurrently mutated in cancer. Most studies of these complexes are focused on their role in regulating protein-coding genes. However, here, we show that SWI/SNF complexes control the expression of microRNAs. We used a SMARCA4-deficient model of lung adenocarcinoma (LUAD) to track changes in the miRNome upon SMARCA4 restoration. We found that SMARCA4-SWI/SNF complexes induced significant changes in the expression of cancer-related microRNAs. The most significantly dysregulated microRNA was miR-222, whose expression was promoted by SMARCA4-SWI/SNF complexes, but not by SMARCA2-SWI/SNF complexes via their direct binding to a miR-222 enhancer region. Importantly, miR-222 expression decreased cell viability, phenocopying the tumor suppressor role of SMARCA4-SWI/SNF complexes in LUAD. Finally, we showed that the miR-222 enhancer region resides in a topologically associating domain that does not contain any cancer-related protein-coding genes, suggesting that miR-222 may be involved in exerting the tumor suppressor role of SMARCA4. Overall, this study highlights the relevant role of the SWI/SNF complex in regulating the non-coding genome, opening new insights into the pathogenesis of LUAD.

摘要

SWI/SNF 染色质重塑复合物是关键的表观遗传调节剂,在癌症中经常发生突变。大多数关于这些复合物的研究都集中在它们对调节蛋白编码基因的作用上。然而,在这里,我们表明 SWI/SNF 复合物控制 microRNA 的表达。我们使用 SMARCA4 缺陷型肺腺癌 (LUAD) 模型来跟踪 SMARCA4 恢复后 miRNome 的变化。我们发现 SMARCA4-SWI/SNF 复合物诱导了与癌症相关的 microRNA 表达的显著变化。最显著失调的 microRNA 是 miR-222,其表达受 SMARCA4-SWI/SNF 复合物促进,但不受 SMARCA2-SWI/SNF 复合物通过其直接结合到 miR-222 增强子区域的影响。重要的是,miR-222 的表达降低了细胞活力,模拟了 SMARCA4-SWI/SNF 复合物在 LUAD 中的肿瘤抑制作用。最后,我们表明 miR-222 增强子区域位于拓扑关联域内,该区域不包含任何与癌症相关的蛋白编码基因,表明 miR-222 可能参与发挥 SMARCA4 的肿瘤抑制作用。总的来说,这项研究强调了 SWI/SNF 复合物在调节非编码基因组中的相关作用,为 LUAD 的发病机制提供了新的见解。

相似文献

2
SWI/SNF complex-deficient soft tissue neoplasms: An update.
Semin Diagn Pathol. 2021 May;38(3):222-231. doi: 10.1053/j.semdp.2020.05.005. Epub 2020 Jun 5.
4
Expression inactivation of SMARCA4 by microRNAs in lung tumors.
Hum Mol Genet. 2015 Mar 1;24(5):1400-9. doi: 10.1093/hmg/ddu554. Epub 2014 Oct 29.
7
SMARCA4 and SMARCA2 deficiency in non-small cell lung cancer: immunohistochemical survey of 316 consecutive specimens.
Ann Diagn Pathol. 2017 Feb;26:47-51. doi: 10.1016/j.anndiagpath.2016.10.006. Epub 2016 Oct 20.
9
Residual complexes containing SMARCA2 (BRM) underlie the oncogenic drive of SMARCA4 (BRG1) mutation.
Mol Cell Biol. 2014 Mar;34(6):1136-44. doi: 10.1128/MCB.01372-13. Epub 2014 Jan 13.
10
SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
Oncogene. 2021 Jul;40(28):4652-4662. doi: 10.1038/s41388-021-01875-6. Epub 2021 Jun 17.

引用本文的文献

1
The role of SMARCA4 in lung cancer.
Sci Rep. 2025 Aug 5;15(1):28605. doi: 10.1038/s41598-025-13913-4.
2
Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications.
Front Oncol. 2021 Oct 15;11:708765. doi: 10.3389/fonc.2021.708765. eCollection 2021.

本文引用的文献

1
Mammalian SWI/SNF continuously restores local accessibility to chromatin.
Nat Genet. 2021 Mar;53(3):279-287. doi: 10.1038/s41588-020-00768-w. Epub 2021 Feb 8.
2
Comprehensive Analysis of SWI/SNF Inactivation in Lung Adenocarcinoma Cell Models.
Cancers (Basel). 2020 Dec 10;12(12):3712. doi: 10.3390/cancers12123712.
3
Mammalian SWI/SNF Chromatin Remodeling Complexes: Emerging Mechanisms and Therapeutic Strategies.
Trends Genet. 2020 Dec;36(12):936-950. doi: 10.1016/j.tig.2020.07.011. Epub 2020 Aug 29.
5
The SWI/SNF complex in cancer - biology, biomarkers and therapy.
Nat Rev Clin Oncol. 2020 Jul;17(7):435-448. doi: 10.1038/s41571-020-0357-3. Epub 2020 Apr 17.
6
Polycomb regulation is coupled to cell cycle transition in pluripotent stem cells.
Sci Adv. 2020 Mar 4;6(10):eaay4768. doi: 10.1126/sciadv.aay4768. eCollection 2020 Mar.
8
Modular Organization and Assembly of SWI/SNF Family Chromatin Remodeling Complexes.
Cell. 2018 Nov 15;175(5):1272-1288.e20. doi: 10.1016/j.cell.2018.09.032. Epub 2018 Oct 18.
9
Comprehensive Characterization of Cancer Driver Genes and Mutations.
Cell. 2018 Apr 5;173(2):371-385.e18. doi: 10.1016/j.cell.2018.02.060.
10
Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers.
Nat Struct Mol Biol. 2018 Jan;25(1):61-72. doi: 10.1038/s41594-017-0007-3. Epub 2017 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验